Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation
Author(s) -
Ram Vasudevan Nampoothiri,
Shiyi Chen,
Ivan Pašić,
Zeyad AlShaibani,
Wilson Lam,
Fotios V. Michelis,
Dennis Kim,
Auro Viswabandya,
Armin Gerbitz,
Jeffrey H. Lipton,
Rajat Kumar,
Jonas Mattsson,
Arjun Law
Publication year - 2020
Publication title -
hematology/oncology and stem cell therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 22
eISSN - 1658-3876
pISSN - 2589-0646
DOI - 10.1016/j.hemonc.2020.09.001
Subject(s) - myeloid leukemia , medicine , stem cell , hematopoietic stem cell transplantation , transplantation , haematopoiesis , oncology , leukemia , immunology , biology , genetics
Unsuccessful cytogenetic (US) analysis at baseline has been reported to be a poor prognostic feature in patients with acute myeloid leukemia (AML). We conducted this study to examine the prognostic impact of UC/inconclusive cytogenetic analysis on outcomes in patients with AML undergoing allogeneic hematopoietic stem cell transplantation (Allo HSCT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom